Cargando…
Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance
OBJECTIVE: To evaluate the safety and efficacy of percutaneous cystolitholapaxy (PCCL) under cystoscopic guidance and without fluoroscopy for the management of large or multiple bladder stones. PATIENTS AND METHODS: Prospectively collected data were reviewed for patients undergoing PCCL with cystosc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983157/ https://www.ncbi.nlm.nih.gov/pubmed/27547463 http://dx.doi.org/10.1016/j.aju.2016.05.001 |
_version_ | 1782447873926889472 |
---|---|
author | Metwally, Adel H. Sherief, Mahmoud H. Elkoushy, Mohamed A. |
author_facet | Metwally, Adel H. Sherief, Mahmoud H. Elkoushy, Mohamed A. |
author_sort | Metwally, Adel H. |
collection | PubMed |
description | OBJECTIVE: To evaluate the safety and efficacy of percutaneous cystolitholapaxy (PCCL) under cystoscopic guidance and without fluoroscopy for the management of large or multiple bladder stones. PATIENTS AND METHODS: Prospectively collected data were reviewed for patients undergoing PCCL with cystoscopic guidance and without fluoroscopy. Patients with a bladder stone burden of ⩾30 mm were included. Stone fragmentation was achieved using a pneumatic lithotripter through a rigid nephroscope and the fragments were removed with peanut forceps. Patients with concomitant bladder malignancy, previous pelvic radiotherapy, previous pelvic–abdominal surgery, or benign prostate enlargement of >80 mL were excluded from the study. RESULTS: In all, 40 male patients were included between July 2011 and June 2014 with a mean (SD) age of 36.9 (17.6) years. A single bladder stone was detected in 22 (55%) patients, whilst 18 (45%) had multiple bladder stones, with a mean (range) stone size of 35 (32–45) mm. The stone-free rate was 100% and the procedure was well tolerated by all patients. No intraoperative bladder perforation, bleeding or major perioperative adverse events were recorded. The mean (SD) hospital stay was 2.2 (0.41) days and the catheterisation time was 1.2 (0.6) days. At 4 weeks postoperatively, no significant stone fragments were found in any of the patients. CONCLUSION: PCCL under cystoscopic control and without fluoroscopy seems to be an effective and safe technique to remove large or multiple bladder calculi. It represents an alternative treatment option, especially in situations where fluoroscopy is not available, and radiation hazards can be avoided. |
format | Online Article Text |
id | pubmed-4983157 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-49831572016-08-19 Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance Metwally, Adel H. Sherief, Mahmoud H. Elkoushy, Mohamed A. Arab J Urol Original Article OBJECTIVE: To evaluate the safety and efficacy of percutaneous cystolitholapaxy (PCCL) under cystoscopic guidance and without fluoroscopy for the management of large or multiple bladder stones. PATIENTS AND METHODS: Prospectively collected data were reviewed for patients undergoing PCCL with cystoscopic guidance and without fluoroscopy. Patients with a bladder stone burden of ⩾30 mm were included. Stone fragmentation was achieved using a pneumatic lithotripter through a rigid nephroscope and the fragments were removed with peanut forceps. Patients with concomitant bladder malignancy, previous pelvic radiotherapy, previous pelvic–abdominal surgery, or benign prostate enlargement of >80 mL were excluded from the study. RESULTS: In all, 40 male patients were included between July 2011 and June 2014 with a mean (SD) age of 36.9 (17.6) years. A single bladder stone was detected in 22 (55%) patients, whilst 18 (45%) had multiple bladder stones, with a mean (range) stone size of 35 (32–45) mm. The stone-free rate was 100% and the procedure was well tolerated by all patients. No intraoperative bladder perforation, bleeding or major perioperative adverse events were recorded. The mean (SD) hospital stay was 2.2 (0.41) days and the catheterisation time was 1.2 (0.6) days. At 4 weeks postoperatively, no significant stone fragments were found in any of the patients. CONCLUSION: PCCL under cystoscopic control and without fluoroscopy seems to be an effective and safe technique to remove large or multiple bladder calculi. It represents an alternative treatment option, especially in situations where fluoroscopy is not available, and radiation hazards can be avoided. Elsevier 2016-06-07 /pmc/articles/PMC4983157/ /pubmed/27547463 http://dx.doi.org/10.1016/j.aju.2016.05.001 Text en © 2016 Arab Association of Urology. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Metwally, Adel H. Sherief, Mahmoud H. Elkoushy, Mohamed A. Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title | Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title_full | Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title_fullStr | Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title_full_unstemmed | Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title_short | Safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
title_sort | safety and efficacy of cystoscopically guided percutaneous suprapubic cystolitholapaxy without fluoroscopic guidance |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983157/ https://www.ncbi.nlm.nih.gov/pubmed/27547463 http://dx.doi.org/10.1016/j.aju.2016.05.001 |
work_keys_str_mv | AT metwallyadelh safetyandefficacyofcystoscopicallyguidedpercutaneoussuprapubiccystolitholapaxywithoutfluoroscopicguidance AT sheriefmahmoudh safetyandefficacyofcystoscopicallyguidedpercutaneoussuprapubiccystolitholapaxywithoutfluoroscopicguidance AT elkoushymohameda safetyandefficacyofcystoscopicallyguidedpercutaneoussuprapubiccystolitholapaxywithoutfluoroscopicguidance |